Literature DB >> 23834324

Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters.

Amir Nasrolahi Shirazi1, Rakesh Kumar Tiwari, Donghoon Oh, Brian Sullivan, Kellen McCaffrey, Dindyal Mandal, Keykavous Parang.   

Abstract

Gold nanoparticles (AuNPs) were synthesized in situ in a green and rapid method from the reaction of reducing linear and cyclic peptides containing tryptophan and lysine residues, (KW)5 and cyclic [KW]5, with an aqueous solution of HAuCl4 and were evaluated as cellular nanodrug delivery systems. The cyclic or linear nature of the peptide was found to determine the morphology and size of the formed peptide-AuNPs and their in vitro molecular transporting efficiency. While cyclic [KW]5-AuNPs formed sponge-like agglomerates, linear (KW)5-AuNPs demonstrated ball-shaped structures. A comparative flow cytometry study showed that the cellular uptake of fluorescence-labeled anti-HIV drugs (emtricitabine (FTC) and lamivudine (3TC)) in human leukemia (CCRF-CEM) cells, and a negatively charged cell-impermeable phosphopeptide (GpYEEI) in human ovarian adecarcinoma (SK-OV-3) cells was significantly higher in the presence of cyclic [KW]5-AuNPs than that of linear (KW)5-AuNPs, parent cyclic [KW]5, and linear (KW)5 peptides. For example, the cellular uptake of F'-GpYEEI was enhanced 12.8-fold by c[KW]5-AuNPs. Confocal microscopy revealed the localization of fluorescence-labeled-3TC in the presence of c[KW]5-AuNPs mostly in nucleus in SK-OV-3 cells after 1 h. On the other hand, l(KW)5-AuNPs delivered fluorescence-labeled-3TC in cytoplasm. These data suggest that noncell penetrating peptides can be converted to efficient molecular transporters through peptide-capped AuNPs formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23834324      PMCID: PMC3810956          DOI: 10.1021/mp400199e

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  38 in total

Review 1.  Emtricitabine (FTC) for the treatment of HIV infection.

Authors:  M Nelson; M Schiavone
Journal:  Int J Clin Pract       Date:  2004-05       Impact factor: 2.503

2.  Drug delivery systems: entering the mainstream.

Authors:  Theresa M Allen; Pieter R Cullis
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

Review 3.  The nuclear pore complex: the gateway to successful nonviral gene delivery.

Authors:  Marieke A E M van der Aa; Enrico Mastrobattista; Ronald S Oosting; Wim E Hennink; Gerben A Koning; Daan J A Crommelin
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

4.  Long unfolded linkers facilitate membrane protein import through the nuclear pore complex.

Authors:  Anne C Meinema; Justyna K Laba; Rizqiya A Hapsari; Renee Otten; Frans A A Mulder; Annemarie Kralt; Geert van den Bogaart; C Patrick Lusk; Bert Poolman; Liesbeth M Veenhoff
Journal:  Science       Date:  2011-06-09       Impact factor: 47.728

Review 5.  Structure and design of polymeric surfactant-based drug delivery systems.

Authors:  V P Torchilin
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

6.  Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Donghoon Oh; Antara Banerjee; Arpita Yadav; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

7.  Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?

Authors:  Alaaldin M Alkilany; Catherine J Murphy
Journal:  J Nanopart Res       Date:  2010-04-06       Impact factor: 2.253

8.  Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells.

Authors:  Chae Kyu Kim; Partha Ghosh; Chiara Pagliuca; Zheng-Jiang Zhu; Stefano Menichetti; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

9.  Simultaneous nuclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes.

Authors:  Jia-nan Liu; Wenbo Bu; Li-min Pan; Shengjian Zhang; Feng Chen; Liangping Zhou; Kuai-le Zhao; Weijun Peng; Jianlin Shi
Journal:  Biomaterials       Date:  2012-07-12       Impact factor: 12.479

10.  Nuclear transport of single molecules: dwell times at the nuclear pore complex.

Authors:  Ulrich Kubitscheck; David Grünwald; Andreas Hoekstra; Daniel Rohleder; Thorsten Kues; Jan Peter Siebrasse; Reiner Peters
Journal:  J Cell Biol       Date:  2005-01-17       Impact factor: 10.539

View more
  9 in total

1.  Synthesis and in vitro evaluation of amphiphilic peptides and their nanostructured conjugates.

Authors:  Samaneh Mohammadi; Javid Shahbazi Mojarrad; Parvin Zakeri-Milani; Ali Shirani; Samad Mussa Farkhani; Naser Samadi; Hadi Valizadeh
Journal:  Adv Pharm Bull       Date:  2015-03-05

Review 2.  Self-assembly of peptides to nanostructures.

Authors:  Dindyal Mandal; Amir Nasrolahi Shirazi; Keykavous Parang
Journal:  Org Biomol Chem       Date:  2014-04-23       Impact factor: 3.876

3.  Peptide amphiphile containing arginine and fatty acyl chains as molecular transporters.

Authors:  Amir Nasrolahi Shirazi; Donghoon Oh; Rakesh Kumar Tiwari; Brian Sullivan; Anju Gupta; Geoffrey D Bothun; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-11-12       Impact factor: 4.939

Review 4.  Off to the organelles - killing cancer cells with targeted gold nanoparticles.

Authors:  Mohamed Kodiha; Yi Meng Wang; Eliza Hutter; Dusica Maysinger; Ursula Stochaj
Journal:  Theranostics       Date:  2015-01-21       Impact factor: 11.556

5.  Cyclic peptide-selenium nanoparticles as drug transporters.

Authors:  Amir Nasrolahi Shirazi; Rakesh K Tiwari; Donghoon Oh; Brian Sullivan; Anil Kumar; Yousef A Beni; Keykavous Parang
Journal:  Mol Pharm       Date:  2014-09-17       Impact factor: 4.939

6.  Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens.

Authors:  Donghoon Oh; Jiadong Sun; Amir Nasrolahi Shirazi; Kerry L LaPlante; David C Rowley; Keykavous Parang
Journal:  Mol Pharm       Date:  2014-09-04       Impact factor: 4.939

Review 7.  A Global Review on Short Peptides: Frontiers and Perspectives.

Authors:  Vasso Apostolopoulos; Joanna Bojarska; Tsun-Thai Chai; Sherif Elnagdy; Krzysztof Kaczmarek; John Matsoukas; Roger New; Keykavous Parang; Octavio Paredes Lopez; Hamideh Parhiz; Conrad O Perera; Monica Pickholz; Milan Remko; Michele Saviano; Mariusz Skwarczynski; Yefeng Tang; Wojciech M Wolf; Taku Yoshiya; Janusz Zabrocki; Piotr Zielenkiewicz; Maha AlKhazindar; Vanessa Barriga; Konstantinos Kelaidonis; Elham Mousavinezhad Sarasia; Istvan Toth
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

8.  Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization.

Authors:  Donghoon Oh; Amir Nasrolahi Shirazi; Kevin Northup; Brian Sullivan; Rakesh Kumar Tiwari; Marco Bisoffi; Keykavous Parang
Journal:  Mol Pharm       Date:  2014-07-15       Impact factor: 4.939

9.  Novel pH-Sensitive Cyclic Peptides.

Authors:  Dhammika Weerakkody; Anna Moshnikova; Naglaa Salem El-Sayed; Ramona-Cosmina Adochite; Gregory Slaybaugh; Jovana Golijanin; Rakesh K Tiwari; Oleg A Andreev; Keykavous Parang; Yana K Reshetnyak
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.